Trial Outcomes & Findings for Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections (NCT NCT02385708)
NCT ID: NCT02385708
Last Updated: 2019-04-30
Results Overview
Number of participants who had surgical site infection development at 30 day post operative visit based on Center for Disease Control Criteria for Defining A Surgical Site Infection (SSI), 2011.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
163 participants
Primary outcome timeframe
30 days
Results posted on
2019-04-30
Participant Flow
Participant milestones
| Measure |
Standard of Care
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
Treatment Arm
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
|---|---|---|
|
Overall Study
STARTED
|
81
|
82
|
|
Overall Study
Intervention Started
|
81
|
82
|
|
Overall Study
COMPLETED
|
73
|
67
|
|
Overall Study
NOT COMPLETED
|
8
|
15
|
Reasons for withdrawal
| Measure |
Standard of Care
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
Treatment Arm
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
0
|
2
|
|
Overall Study
Withdrawn - surgery canceled
|
2
|
5
|
|
Overall Study
Investigator decision
|
5
|
7
|
|
Overall Study
Protocol Violation
|
1
|
1
|
Baseline Characteristics
Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections
Baseline characteristics by cohort
| Measure |
Standard of Care
n=73 Participants
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
Treatment Arm
n=67 Participants
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
Total
n=140 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
48 Participants
n=5 Participants
|
39 Participants
n=7 Participants
|
87 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
25 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
26 Participants
n=5 Participants
|
24 Participants
n=7 Participants
|
50 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
47 Participants
n=5 Participants
|
43 Participants
n=7 Participants
|
90 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
72 Participants
n=5 Participants
|
67 Participants
n=7 Participants
|
139 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
8 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
65 Participants
n=5 Participants
|
66 Participants
n=7 Participants
|
131 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
73 participants
n=5 Participants
|
67 participants
n=7 Participants
|
140 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 30 daysNumber of participants who had surgical site infection development at 30 day post operative visit based on Center for Disease Control Criteria for Defining A Surgical Site Infection (SSI), 2011.
Outcome measures
| Measure |
Standard of Care
n=73 Participants
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
Treatment Arm
n=67 Participants
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
|---|---|---|
|
Incidence of Surgical Site Infections
|
0 Participants
|
0 Participants
|
Adverse Events
Standard of Care
Serious events: 1 serious events
Other events: 2 other events
Deaths: 0 deaths
Treatment Arm
Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Standard of Care
n=81 participants at risk
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
Treatment Arm
n=82 participants at risk
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
|---|---|---|
|
Gastrointestinal disorders
Anastomotic leak
|
1.2%
1/81 • Number of events 1 • From one day prior to surgery to post operative day 4
|
0.00%
0/82 • From one day prior to surgery to post operative day 4
|
Other adverse events
| Measure |
Standard of Care
n=81 participants at risk
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
Treatment Arm
n=82 participants at risk
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge
2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
|
|---|---|---|
|
Nervous system disorders
Acute altered mental status change
|
0.00%
0/81 • From one day prior to surgery to post operative day 4
|
1.2%
1/82 • Number of events 1 • From one day prior to surgery to post operative day 4
|
|
Gastrointestinal disorders
nausea/vomiting/dehydration
|
0.00%
0/81 • From one day prior to surgery to post operative day 4
|
1.2%
1/82 • Number of events 1 • From one day prior to surgery to post operative day 4
|
|
Skin and subcutaneous tissue disorders
skin rash and itching
|
0.00%
0/81 • From one day prior to surgery to post operative day 4
|
1.2%
1/82 • Number of events 1 • From one day prior to surgery to post operative day 4
|
|
Cardiac disorders
new onset atrial fibrillation with rapid ventricular response
|
1.2%
1/81 • Number of events 1 • From one day prior to surgery to post operative day 4
|
0.00%
0/82 • From one day prior to surgery to post operative day 4
|
|
Cardiac disorders
persistent tachycardia with hemodynamic instability
|
1.2%
1/81 • Number of events 1 • From one day prior to surgery to post operative day 4
|
0.00%
0/82 • From one day prior to surgery to post operative day 4
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place